Machine-learning strategy for high error tolerance in image-based digital molecular assays

preprint OA: closed

Abstract

There is a significant global health need to translate more in vitro diagnostic tests (IVDs) from clinical laboratories to field-based applications, including point-of-care (POC) and self-administered test formats. These applications typically require smaller sample sizes, limit the extent of sample processing and measurement capabilities, and introduce greater handling variability. Error tolerance is one of the most critical factors for successful field-based assay design. Here, we examine machine-learning (ML) strategies to enhance the error tolerance of image-based nanoparticle immunoassays. Random dispersions of nanoparticles were imaged in microliter sample volumes, and images were processed to determine analyte concentrations based on nanoparticle appearance. Assay performance was characterized using two common blood diagnostics: C-reactive protein (CRP) and S.CoV-2 IgG. We compare the results from a conventional image analysis, a hybrid ML-conventional approach based on pixel segmentation, and a full end-to-end image regression using a targeted regularization strategy. Training images for the full image regression approach required only a single label for training – the analyte concentration – eliminating the need for labor-intensive pixel-level labeling. Ultimately, the fully ML-based analysis significantly improved dynamic range, sensitivity, and reproducibility in high-error settings, including direct measurements performed in whole blood.
Full text 1,607 characters · extracted from oa-doi-fallback · click to expand
Abstract There is a significant global health need to translate more in vitro diagnostic tests (IVDs) from clinical laboratories to field-based applications, including point-of-care (POC) and self-administered test formats. These applications typically require smaller sample sizes, limit the extent of sample processing and measurement capabilities, and introduce greater handling variability. Error tolerance is one of the most critical factors for successful field-based assay design. Here, we examine machine-learning (ML) strategies to enhance the error tolerance of image-based nanoparticle immunoassays. Random dispersions of nanoparticles were imaged in microliter sample volumes, and images were processed to determine analyte concentrations based on nanoparticle appearance. Assay performance was characterized using two common blood diagnostics: C-reactive protein (CRP) and S.CoV-2 IgG. We compare the results from a conventional image analysis, a hybrid ML-conventional approach based on pixel segmentation, and a full end-to-end image regression using a targeted regularization strategy. Training images for the full image regression approach required only a single label for training – the analyte concentration – eliminating the need for labor-intensive pixel-level labeling. Ultimately, the fully ML-based analysis significantly improved dynamic range, sensitivity, and reproducibility in high-error settings, including direct measurements performed in whole blood. Competing Interest Statement The authors DBM and JTG have financial interest in the company ilytica which funded this study.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00